AestheticsFeatured Articles

Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement

By August 25, 2020No Comments

Featured Article

Featured Article

A survey was conducted at a single dermatology center to determine if there was an increased trend in cosmetic procedures in patients with moderate to severe psoriasis who attained 75% or greater reduction of the body surface area (BSA) with biologic agents and oral systemic therapies, and if this was related to an improvement in quality of life following psoriasis clearance.

Read more

A survey was conducted at a single dermatology center to determine if there was an increased trend in cosmetic procedures in patients with moderate to severe psoriasis who attained 75% or greater reduction of the body surface area (BSA) with biologic agents and oral systemic therapies, and if this was related to an improvement in quality of life following psoriasis clearance.

Michelle E. Walters MD, Delphine J. Lee MD PhD, Paul S. Yamauchi MD PhD

Psoriasis is a chronic skin condition with a negative impact on patient quality of life. The National Psoriasis Foundation states that an acceptable response to psoriasis treatment is at least a 75% reduction in body surface area (BSA) at 3 months after initiation of treatment.

This reduction in BSA has been associated with improvement in quality of life, with clearance rates of clear to almost clear leading to an even greater improvement in quality of life.2,3 To date, there have been no studies examining the relationship between improvement in quality of life following a reduction in BSA, and the increased utilization of cosmetic procedures. Here, we examine the relationship between quality of life and the use of various cosmetic procedures in patients treated for psoriasis with systemic and biologic therapies who achieved at least 75% reduction in BSA.

This was a retrospective study assessing quality of life and the use of cosmetic procedures in psoriasis patients after attaining a75% or greater reduction of the body surface area with biologic agents only, systemic agents only, or a combination of both. This study was conducted according to the ethical guidelines of the 1975 Declaration of Helsinki. All patients provided informed consent.

Read Full Article Now
Article Cited in this Post

You May Also Like

JDD in the News: Acne Information on Instagram, CAL/BDP Cream Improves QoL

| Featured Articles, JDD Highlights, JDD Higlights, JDD in the Media, The Latest | No Comments
By Allison Sit HCP Live covered a March JDD study in its article, “Acne-Related Social Media Content Lacking Dermatologist Input.” The study, “Acne Information on Instagram: Quality of Content and…

Novel Biome-Care Technology of C. acnes subsp. defendens Demonstrates Health and Aesthetic Benefits for Facial Skin

| Featured Articles, JDD Highlights, JDD Webinars, Rosacea, The Latest, Webinars on Demand | No Comments
As one ages, changes to skin biology can result in a shift in the skin biome causing microbial imbalance (dysbiosis) and significant reductions in certain microbial populations that maintain skin…

JDD in the News: AI Perceptions, Platelet Count & Psoriasis

| Featured Articles, JDD Highlights, JDD Higlights, JDD in the Media, The Latest | No Comments
By Allison Sit Dermatology News, Dermatology Times and Practical Dermatology all wrote about the February JDD study, “Perceptions of Artificial Intelligence Integration into Dermatology Clinical Practice: A Cross-Sectional Survey Study.”…

Leave a Reply